Pimecrolimus 1% cream for cutaneous lupus erythematosus
- 30 September 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 51 (3), 407-410
- https://doi.org/10.1016/j.jaad.2004.01.044
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- 0.1% Tacrolimus ointment in a patient with subacute cutaneous lupus erythematosusJournal of Dermatological Treatment, 2004
- Successful Treatment of Anogenital Lichen Sclerosus With Topical TacrolimusArchives of Dermatology, 2003
- Efficacy of topical tacrolimus for treating the malar rash of systemic lupus erythematosus.British Journal of Dermatology, 2003
- Cutaneous Lupus ErythematosusAmerican Journal of Clinical Dermatology, 2003
- Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescentsJournal of the American Academy of Dermatology, 2002
- Lupus Erythematosus TumidusArchives of Dermatology, 2000
- A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacologyBritish Journal of Dermatology, 1999
- TacrolimusArchives of Dermatology, 1999
- Topical Tacrolimus Is Not Effective in Chronic Plaque PsoriasisArchives of Dermatology, 1998
- A Short-Term Trial of Tacrolimus Ointment for Atopic DermatitisNew England Journal of Medicine, 1997